New AMI Guidelines

Allan S Jaffe, Peter L. Thompson

Research output: Contribution to journalArticle

Abstract

Cardiovascular disease is a global health problem. Approximately one-third of persons in the world die of cardiovascular disease and a large proportion of these deaths is due to coronary heart disease, of which myocardial infarction (MI) is a major manifestation. As one of the leading health problems in the world, MI is an important outcome measure in clinical trials and observational studies. MI may be defined from a number of different clinical, electrocardiographic, biochemical, imaging, and pathological characteristics. For some time, a general consensus existed for the clinical syndrome designated as MI. As just one example, the World Health Organization for many years defined MI based on symptoms, electrocardiographic abnormalities, and enzymes. However, as more specific biomarkers of myocardial necrosis and more precise imaging techniques became available, the accuracy of detecting MI has changed dramatically. In response, the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) jointly developed a new definition of MI that was published in 2000. Given the considerable advances in the diagnosis and management of MI since then, the leadership of the ESC, ACC, American Heart Association (AHA), and World Heart Federation (WHF) developed a Global Task Force to update the earlier consensus document. This new universal definition of MI was published in late 2007.

Original languageEnglish (US)
Pages (from-to)28-31
Number of pages4
JournalACC Cardiosource Review Journal
Volume17
Issue number4
StatePublished - Apr 2008

Fingerprint

Myocardial Infarction
Guidelines
Cardiology
Consensus
Cardiovascular Diseases
Advisory Committees
Observational Studies
Coronary Disease
Necrosis
Biomarkers
Outcome Assessment (Health Care)
Clinical Trials
Health
Enzymes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Nursing(all)

Cite this

Jaffe, A. S., & Thompson, P. L. (2008). New AMI Guidelines. ACC Cardiosource Review Journal, 17(4), 28-31.

New AMI Guidelines. / Jaffe, Allan S; Thompson, Peter L.

In: ACC Cardiosource Review Journal, Vol. 17, No. 4, 04.2008, p. 28-31.

Research output: Contribution to journalArticle

Jaffe, AS & Thompson, PL 2008, 'New AMI Guidelines', ACC Cardiosource Review Journal, vol. 17, no. 4, pp. 28-31.
Jaffe AS, Thompson PL. New AMI Guidelines. ACC Cardiosource Review Journal. 2008 Apr;17(4):28-31.
Jaffe, Allan S ; Thompson, Peter L. / New AMI Guidelines. In: ACC Cardiosource Review Journal. 2008 ; Vol. 17, No. 4. pp. 28-31.
@article{2a8f22e639344f1ebe6055afcd098386,
title = "New AMI Guidelines",
abstract = "Cardiovascular disease is a global health problem. Approximately one-third of persons in the world die of cardiovascular disease and a large proportion of these deaths is due to coronary heart disease, of which myocardial infarction (MI) is a major manifestation. As one of the leading health problems in the world, MI is an important outcome measure in clinical trials and observational studies. MI may be defined from a number of different clinical, electrocardiographic, biochemical, imaging, and pathological characteristics. For some time, a general consensus existed for the clinical syndrome designated as MI. As just one example, the World Health Organization for many years defined MI based on symptoms, electrocardiographic abnormalities, and enzymes. However, as more specific biomarkers of myocardial necrosis and more precise imaging techniques became available, the accuracy of detecting MI has changed dramatically. In response, the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) jointly developed a new definition of MI that was published in 2000. Given the considerable advances in the diagnosis and management of MI since then, the leadership of the ESC, ACC, American Heart Association (AHA), and World Heart Federation (WHF) developed a Global Task Force to update the earlier consensus document. This new universal definition of MI was published in late 2007.",
author = "Jaffe, {Allan S} and Thompson, {Peter L.}",
year = "2008",
month = "4",
language = "English (US)",
volume = "17",
pages = "28--31",
journal = "ACC Cardiosource Review Journal",
issn = "1556-8571",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - New AMI Guidelines

AU - Jaffe, Allan S

AU - Thompson, Peter L.

PY - 2008/4

Y1 - 2008/4

N2 - Cardiovascular disease is a global health problem. Approximately one-third of persons in the world die of cardiovascular disease and a large proportion of these deaths is due to coronary heart disease, of which myocardial infarction (MI) is a major manifestation. As one of the leading health problems in the world, MI is an important outcome measure in clinical trials and observational studies. MI may be defined from a number of different clinical, electrocardiographic, biochemical, imaging, and pathological characteristics. For some time, a general consensus existed for the clinical syndrome designated as MI. As just one example, the World Health Organization for many years defined MI based on symptoms, electrocardiographic abnormalities, and enzymes. However, as more specific biomarkers of myocardial necrosis and more precise imaging techniques became available, the accuracy of detecting MI has changed dramatically. In response, the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) jointly developed a new definition of MI that was published in 2000. Given the considerable advances in the diagnosis and management of MI since then, the leadership of the ESC, ACC, American Heart Association (AHA), and World Heart Federation (WHF) developed a Global Task Force to update the earlier consensus document. This new universal definition of MI was published in late 2007.

AB - Cardiovascular disease is a global health problem. Approximately one-third of persons in the world die of cardiovascular disease and a large proportion of these deaths is due to coronary heart disease, of which myocardial infarction (MI) is a major manifestation. As one of the leading health problems in the world, MI is an important outcome measure in clinical trials and observational studies. MI may be defined from a number of different clinical, electrocardiographic, biochemical, imaging, and pathological characteristics. For some time, a general consensus existed for the clinical syndrome designated as MI. As just one example, the World Health Organization for many years defined MI based on symptoms, electrocardiographic abnormalities, and enzymes. However, as more specific biomarkers of myocardial necrosis and more precise imaging techniques became available, the accuracy of detecting MI has changed dramatically. In response, the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) jointly developed a new definition of MI that was published in 2000. Given the considerable advances in the diagnosis and management of MI since then, the leadership of the ESC, ACC, American Heart Association (AHA), and World Heart Federation (WHF) developed a Global Task Force to update the earlier consensus document. This new universal definition of MI was published in late 2007.

UR - http://www.scopus.com/inward/record.url?scp=43349093495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43349093495&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 28

EP - 31

JO - ACC Cardiosource Review Journal

JF - ACC Cardiosource Review Journal

SN - 1556-8571

IS - 4

ER -